Canopy Growth shares plunge after analysts' warnings
Canopy Growth stock fell 10% last week after Rupesh Parikh, an analyst at the investment bank Oppenheimer, warned that investors should brace for heavy losses in the coming years.
Rupesh Parikh expects Canopy Growth to post losses of more than $500 million over the next two years, with the company’s return to profitability further off than many investors hope.
Canopy Growth is currently the largest cannabis company by market capitalization and a popular stock among cannabis investors, partly because of the company's substantial cash reserves. Canopy's financial strength stems primarily from the investment by $4 billion generated by Constellation Brands, which enabled the beer giant to hold nearly 40% of the cannabis producer.
Canopy’s operating losses are, however, reducing its cash position. Canopy generated a negative operating cash flow of 158 million Canadian dollars and a negative free cash flow of 372 million Canadian dollars in the last quarter. The company has struggled with both supply shortages in some markets and oversupply issues in others. This has led to revenue losses and lower margins. It is also acquiring companies at a rapid pace, an investment strategy that will strengthen its results in the medium to long term.
These problems have also caused upheaval among Canopy's leadership. Co-founder and co-CEO Bruce Linton, was ousted in July, partly due to Constellation Brands' frustration with Canopy's mounting losses. A new CEO has not yet been named
Despite this uncertainty regarding Canopy’s profitability, Rupesh Parikh predicts that the company’s shares will still trade at seven times its estimated 2021 revenue. For these reasons, the analyst recommends that investors hold off on buying shares until their valuation improves, but has declined to set a price target at this time.
-
Cannabis in France4 weeks ago
The «cannabis» fine raised to 500 euros under the RIPOST Act
-
Cannabis in Nepal2 weeks ago
A Nepalese province legalizes medical cannabis
-
Cannabis in France2 weeks ago
French Polynesia Is Finally Ready to Launch Its «Medical Cannabis» Pilot Program After Months of Delays
-
Cannabis in Spain4 weeks ago
The First Authorized Medical Cannabis Cultivation in the Canary Islands
-
Business4 weeks ago
Germany Ends Public Health Insurance Coverage for Medical Cannabis Flowers
-
Cannabis in California2 weeks ago
Eight years after legalization, cannabis use in California has not increased
-
Cannabis in Africa4 weeks ago
Botswana Paves the Way for Commercial Hemp Cultivation
-
Cannabis in India7 days ago
India Approves a Synthetic CBD Drug for Anxiety


You must be logged in to post a comment Login